Dhd Drugs May Increase Risk Of Suicidal Thoughts And Behaviours In Some People; Benefits Still Outweigh Risks

Recall Summary Health Canada has identified that drugs used to treat ADHD (attention-deficit/hyperactivity disorder) may increase the risk of suicidal thoughts and behaviors in some people. The products remain available across Canada because Health Canada determined that the benefits of these medications still outweigh the potential risks for most patients. This safety concern affects people taking ADHD medications throughout Canada.

Reason

Product safety

Category

consumer product recall

Country

Canada

Agency

HC-PRODUCTS

Recall date

2015-03-30

Status

Closed

Distribution

Canada-wide

Official recall notice from HC-PRODUCTS

Recall details on Nibble Recalls: https://trynibble.app/recalls/cb29bb92-516a-4618-a955-714a888ef5f5